Imatinib mesylate in thymic epithelial malignancies.
Palmieri G, Marino M, Buonerba C, Federico P, Conti S, Milella M, Petillo L, Evoli A, Lalle M, Ceribelli A, Merola G, Matano E, Sioletic S, De Placido S, Di Lorenzo G, Damiano V.
Palmieri G, et al. Among authors: conti s.
Cancer Chemother Pharmacol. 2012 Feb;69(2):309-15. doi: 10.1007/s00280-011-1690-0. Epub 2011 Jun 28.
Cancer Chemother Pharmacol. 2012.
PMID: 21710245
Clinical Trial.